Skip to main content

Advertisement

Log in

Exacerbations, Hospital Admissions and Impaired Health Status in Chronic Obstructive Pulmonary Disease

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Impaired health status may be a risk factor for frequent exacerbations and hospital admission and, in turn, exacerbations and admissions may further impair the health status of patients with COPD. We have investigated the variables associated with frequent exacerbations (3 or more per year) and admission, with particular interest in health status, in a cohort of ambulatory patients with moderate to severe COPD attended by chest physicians in Spain. A total of 227 investigators included 1057 patients with a mean predicted FEV1 of 41.8%. The mean total score on the St. George’s Respiratory Questionnaire (SGRQ) was 47.9 units, and 300 patients (28.4%) had 3 or more exacerbations the previous year and 344 (32.6%) were admitted at least once during the same period. In multivariate analysis only the SGRQ total score was significantly associated with both frequent exacerbations (OR = 1.04; 95% CI = 1.01–2.12; p<0.0001) and admission (OR = 1.01; 95% CI = 1.00–1.02; p = 0.0008). Other variables significantly associated with frequent exacerbations were chronic mucus hypersecretion, increased baseline dyspnea, comorbidity, GOLD stage IV and treatment with inhaled corticosteroids. Variables associated with admission were lower educational level, increased number of exacerbations, use of long-term oxygen therapy and use of short acting beta-2 agonists. An impaired health status is associated with an increased number of exacerbations and with admission to hospital in the previous year. These results, together with previous studies, confirm that impairment in health status in COPD is both a marker of risk for, and a consequence of, frequent exacerbations and admissions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. V Sobradillo Pena M Miravitlles R Gabriel et al. (2000) ArticleTitleGeographical variations in prevalence and underdiagnosis of COPD. Results of the IBERPOC multicentre epidemiological study Chest 118 981–989

    Google Scholar 

  2. M Ferrer J Alonso J Morera et al. (1997) ArticleTitleChronic obstructive pulmonary disease stage and health-related quality of life Ann Intern Med 127 1072–1079 Occurrence Handle1:STN:280:DyaK1c%2FkvFOitw%3D%3D Occurrence Handle9412309

    CAS  PubMed  Google Scholar 

  3. Miravitlles M, Murio C, Guerrero T*, Gisbert R on behalf of the DAFNE study group. Costs of chronic bronchitis and COPD. A one year follow-up study. Chest 2003; 123: 784–791.

  4. JF Masa V Sobradillo C Villasante et al. (2004) ArticleTitleCosts of chronic obstructive pulmonary disease in Spain: estimation from a population-based study Arch Bronconeumol 40 72–79 Occurrence Handle1:STN:280:DC%2BD2c%2FksFyktw%3D%3D Occurrence Handle14746730

    CAS  PubMed  Google Scholar 

  5. DE Hilleman N Dewan M Malesker M Friedman (2000) ArticleTitlePharmacoeconomic evaluation of COPD Chest 118 1278–1285 Occurrence Handle10.1378/chest.118.5.1278 Occurrence Handle1:STN:280:DC%2BD3M%2FkvFOgtA%3D%3D Occurrence Handle11083675

    Article  CAS  PubMed  Google Scholar 

  6. Miravitlles M, Mayordomo C, Artés M, Sánchez-Agudo L, Nicolau F, Segú JL on Behalf of the EOLO Group. Treatment of chronic obstructive pulmonary disease and its exacerbations in General Practice. Respir Med 1999; 93: 173–179.

    Google Scholar 

  7. Miravitlles M, Guerrero T, Mayordomo C, Sánchez-Agudo L, Nicolau F, Segú JL on Behalf of the EOLO Study Group. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: A multiple logistic regression analysis. Respiration 2000; 67: 495–501.

    Google Scholar 

  8. Miravitlles M, Murio C, Guerrero T on Behalf of the DAFNE Study Group. Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. A prospective multicenter study in the community. Eur Respir J 2001; 17: 928–933.

    Google Scholar 

  9. SD Aaron KL Vandemheen JJ Clinch et al. (2002) ArticleTitleMeasurement of short-term changes in dyspnea and disease-specific quality of life following an acute COPD exacerbation Chest 121 688–696 Occurrence Handle10.1378/chest.121.3.688 Occurrence Handle11888946

    Article  PubMed  Google Scholar 

  10. Spencer S, Jones PW for the GLOBE Study Group. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 2003; 58: 589–593.

    Google Scholar 

  11. TAR Seemungal GC Donaldson EA Paul JC Bestall DJ Jeffries JA Wedzicha (1998) ArticleTitleEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1418–1422 Occurrence Handle1:STN:280:DyaK1c3msVamtA%3D%3D Occurrence Handle9603117

    CAS  PubMed  Google Scholar 

  12. M Miravitlles M Ferrer A Pont et al. (2004) ArticleTitleExacerbations impair quality of life in patients with chronic obstructive pulmonary disease. A two-year follow-up study Thorax 59 387–395 Occurrence Handle10.1136/thx.2003.008730 Occurrence Handle1:STN:280:DC%2BD2c3jvVOmuw%3D%3D Occurrence Handle15115864

    Article  CAS  PubMed  Google Scholar 

  13. S Spencer PMA Calverley PS Burge PW Jones (2004) ArticleTitleImpact of preventing exacerbations on deterioration of health status in COPD Eur Respir J 23 698–702 Occurrence Handle10.1183/09031936.04.00121404 Occurrence Handle1:STN:280:DC%2BD2czhsVGktg%3D%3D Occurrence Handle15176682

    Article  CAS  PubMed  Google Scholar 

  14. PW Jones FH Quirk CM Baveystock P Littlejohns (1992) ArticleTitleA self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory Questionnaire Am Rev Respir Dis 145 1321–1327 Occurrence Handle1:STN:280:By2B1c7itFw%3D Occurrence Handle1595997

    CAS  PubMed  Google Scholar 

  15. M Ferrer J Alonso L Prieto et al. (1996) ArticleTitleValidity and reliability of the St George’s Respiratory Questionnaire after adaptation to a different language and culture: the Spanish example Eur Respir J 9 1160–1166 Occurrence Handle10.1183/09031936.96.09061160 Occurrence Handle1:STN:280:BymA1MfgsVw%3D Occurrence Handle8804932

    Article  CAS  PubMed  Google Scholar 

  16. Fabbri LM, Hurd SS, for the GOLD Scientific Committee. Global strategy for the diagnosis, management and prevention ofCOPD: 2003 update. EurRespir J 2003; 22: 1–2.

    Google Scholar 

  17. M Miravitlles C Llor K Naberan JM Cots J Molina (2005) ArticleTitleVariables associated with recovery from acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease Respir Med 99 955–965 Occurrence Handle15950136

    PubMed  Google Scholar 

  18. M Miravitlles (2002) ArticleTitleExacerbations of chronic obstructive pulmonary disease: When are bacteria important? Eur Respir J 20 IssueIDSuppl 36 9s–19s

    Google Scholar 

  19. TMA Wilkinson GC Donaldson JR Hurst TAR Seemungal JA Wedzicha (2004) ArticleTitleEarly therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease Am J Respir Crit Care Med 169 1298–1303 Occurrence Handle10.1164/rccm.200310-1443OC Occurrence Handle14990395

    Article  PubMed  Google Scholar 

  20. E Prescott P Lange J Vestbo (1995) ArticleTitleChronic mucus hypersecretion in COPD and death from pulmonary infection Eur Respir J 8 1333–1338 Occurrence Handle10.1183/09031936.95.08081333 Occurrence Handle1:STN:280:BymD1cjlsVA%3D Occurrence Handle7489800

    Article  CAS  PubMed  Google Scholar 

  21. P Lange J Nyboe M Appleyard G Jensen P Schnohr (1990) ArticleTitleRelation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes Thorax 45 579–585 Occurrence Handle1:STN:280:By%2BA1crktFM%3D Occurrence Handle2402719

    CAS  PubMed  Google Scholar 

  22. M Ferrer C Villasante J Alonso et al. (2002) ArticleTitleGeneral population norms of the St. George’s respiratory questionnaire: a strategy to facilitate interpretation of quality of life scores Eur Respir J 19 405–413 Occurrence Handle1:STN:280:DC%2BD383gtlajtw%3D%3D Occurrence Handle11936515

    CAS  PubMed  Google Scholar 

  23. J Miguel Díez ParticleDe JL Izquierdo Alonso JM Rodríguez-González Moro P Lucas Ramos Particlede JM Bellón Cano J Molina París (2004) ArticleTitleQuality of life with chronic obstructive pulmonary disease: the influence of level of patient care Arch Bronconeumol 40 431–437 Occurrence Handle15491533

    PubMed  Google Scholar 

  24. H Doll M Miravitlles (2005) ArticleTitleQuality of life in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. A review of the literature Pharmacoeconomics 23 345–363 Occurrence Handle10.2165/00019053-200523040-00005 Occurrence Handle15853435

    Article  PubMed  Google Scholar 

  25. J Garcia-Aymerich E Monsó RM Marrades et al. (2001) ArticleTitleRisk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study Am J Respir Crit Care Med 164 1002–1007 Occurrence Handle1:STN:280:DC%2BD3MrmtFyqsQ%3D%3D Occurrence Handle11587986

    CAS  PubMed  Google Scholar 

  26. A Domingo-Salvany R Lamarca M Ferrer J García-Aymerich J Alonso M Félez et al. (2002) ArticleTitleHealth-related quality of life and mortality in male patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 166 680–685 Occurrence Handle10.1164/rccm.2112043 Occurrence Handle12204865

    Article  PubMed  Google Scholar 

  27. V Brusasco R Hodder M Miravitlles L Korducki L Towse S Kesten (2003) ArticleTitleHealth outcomes following six months treatment with once daily tiotropium compared to twice daily salmeterol in patients with COPD Thorax 58 399–404 Occurrence Handle1:STN:280:DC%2BD3s3gslajtg%3D%3D Occurrence Handle12728159

    CAS  PubMed  Google Scholar 

  28. M Alvarez-Mon M Miravitlles J Morera L Callol JL Alvarez-Sala (2005) ArticleTitleTreatment with the immunomodulator AM3 improves the health-related quality of life of patients with COPD Chest 127 1212–1218 Occurrence Handle10.1378/chest.127.4.1212 Occurrence Handle1:CAS:528:DC%2BD2MXktVChurg%3D Occurrence Handle15821197

    Article  CAS  PubMed  Google Scholar 

  29. M Miravitlles JL Alvarez-Sala R Lamarca et al. (2002) ArticleTitleTreatment and quality of life in patients with chronic obstructive pulmonary disease Qual Life Res 11 329–338 Occurrence Handle10.1023/A:1015520110663 Occurrence Handle1:STN:280:DC%2BD38zktlegsQ%3D%3D Occurrence Handle12086118

    Article  CAS  PubMed  Google Scholar 

  30. PW Jones LR Willits PS Burge PMA Calverley (2003) ArticleTitleDisease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations Eur Respir J 21 68–73 Occurrence Handle1:CAS:528:DC%2BD3sXhsFahu7Y%3D Occurrence Handle12570111

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marc Miravitlles.

Additional information

The EIME study group Sources of funding: National Science Council (NSC 92-2314-B-010-048).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miravitlles, M., Calle, M., Alvarez-Gutierrez, F. et al. Exacerbations, Hospital Admissions and Impaired Health Status in Chronic Obstructive Pulmonary Disease. Qual Life Res 15, 471–480 (2006). https://doi.org/10.1007/s11136-005-3215-y

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-005-3215-y

Keywords

Navigation